Multiple long-term conditions affect more than 14 per cent of English population
New Imperial led research has found that nearly 15 per cent of people in England are currently living with two or more health disorders.
In Memoriam: Professor Roger M Greenhalgh
Roger M Greenhalgh 1941 - 2023
Understanding immunotherapy-induced colitis to improve cancer patient outcomes
Research shows targeting IFNγ-producing immune cells may reverse CPI-colitis in cancer patients, offering hope for improved outcomes.
New funding for research investigating how breast cancer resists hormone therapy
Imperial researchers have received funding from Breast Cancer Now for research into new treatments for breast cancer that resists hormone therapy.
Imperial innovation recognised at Patient Experience Network National Awards
The Imperial Clinical Analytics, Research and Evaluation (iCARE) team won the Innovative Use of Technology, Social and Digital Media award.
Menstrual cycle changes during the COVID-19 pandemic linked to lifestyle shifts
A new study finds menstrual cycle irregularities during the pandemic could be linked to shifts in behaviour & lifestyle rather than the virus itself.
Infection of certain neurons with COVID could cause persistent symptoms
New research suggests that COVID-19 can lead to the death of neurons known for regulating sexual reproduction and cause persistent symptoms.
Microbiome-derived metabolite plays key role in kidney and heart health
A new study reveals the kidney's function as a key regulator of a metabolite associated with cardiovascular risk.
GLP1 Receptor Mutations: The key to personalised medicine for diabetes & obesity
New research reveals that mutations in the GLP1 receptor significantly impair insulin secretion, disrupt glucose regulation, and increase adiposity.
MRC funding to develop techniques for precision removal of brain cancer cells
Imperial researchers make up one of four teams receiving £500k to work across disciplines on improving outcomes of hard-to-treat cancers.
